Trial Profile
A study of bevacizumab for short term effects on healthy eyes of cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Breast cancer; Colon cancer; Lung cancer
- Focus Pharmacodynamics
- 22 Sep 2015 New trial record